Organization
Beijing Konruns Pharmaceutical
6 clinical trials
Clinical trial
A Randomized, Controlled, Open-label, Multicenter Phase III Study to Evaluate the Efficacy and Safety of KC1036 Versus Investigator's Choice of Chemotherapy as Third-line Therapy in Patients With Advanced Esophageal Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2026-12-30
Clinical trial
A Single-arm, Open, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of KC1036 in the Patients With Advanced Recurrent or Metastatic Thymic TumorsStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
A Phase Ib / II Study to Evaluate the Efficacy and Safety of KC1036 in the Patients With Advanced Recurrent or Metastatic Digestive System TumorsStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
A Phase I, Open-label, Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Preliminary Efficacy of KC1036 in the Patients With Advanced Recurrent or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2023-07-31
Clinical trial
A Phase I Study of KC1036 on Pharmacokinetics to Assess the Effect of High Fat Diet in Chinese Adult Healthy Subjects.Status: Completed, Estimated PCD: 2022-03-23
Clinical trial
A Multicenter, Randomized, Double-blind, Dose-parallel, Placebo-controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of Jincaopian Tablets in Subjects With Chronic Pelvic Pain After Pelvic Inflammatory DiseaseStatus: Recruiting, Estimated PCD: 2024-02-01